Prague Med. Rep. 2019, 120, 10-17

https://doi.org/10.14712/23362936.2019.6

Is Cardiometabolic Index a Predictive Marker for Renal Cell Cancer Aggressiveness?

Murat Dursun1, Huseyin Besiroglu2, Alper Otunctemur3, Emin Ozbek4

1Department of Urology, Malatya Training and Research Hospital, Malatya, Turkey
2Department of Urology, Catalca Ilyas Cokay State Hospital, Istanbul, Turkey
3Department of Urology, Okmeydani Training and Research Hospital, Istanbul, Turkey
4Department of Urology, Istanbul Cerrahpasa Medical Faculty, Istanbul, Turkey

Received October 17, 2018
Accepted May 2, 2019

References

1. Ashwell, M., Gunn, P., Gibson, S. (2012) Waist-to-height ratio is a better screening tool than waist circumference and BMI for adult cardiometabolic risk factors: systematic review and meta-analysis. Obes. Rev. 13(3), 275–286. <https://doi.org/10.1111/j.1467-789X.2011.00952.x>
2. Bergström, A., Hsieh, C. C., Lindblad, P., Lu, C. M., Cook, N. R., Wolk, A. (2001) Obesity and renal cell cancer – a quantitative review. Br. J. Cancer 85, 984–990. <https://doi.org/10.1054/bjoc.2001.2040> <PubMed>
3. Cardillo, M. R., Ippoliti, F. (2007) Interleukin-6, interleukin-10 and heat shock protein-90 expression in renal epithelial neoplasias and surrounding normal-appearing renal parenchyma. Int. J. Immunopathol. Pharmacol. 20, 37–46. <https://doi.org/10.1177/039463200702000105>
4. Cordero, A., Laclaustra, M., León, M., Casasnovas, J. A., Grima, A., Luengo, E., Ordoñez, B., Bergua, C., Bes, M., Pascual, I., Alegría, E.; MESYAS Registry Investigators (2008) Comparison of serum lipid values in subjects with and without the metabolic syndrome. Am. J. Cardiol. 102, 424–428. <https://doi.org/10.1016/j.amjcard.2008.03.079>
5. Edge, S. B., Compton, C. C. (2010) The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann. Surg. Oncol. 17(6), 1471–1474. <https://doi.org/10.1245/s10434-010-0985-4>
6. Ford, E. S., Giles, W. H., Dietz, W. H. (2002) Prevalence of the metabolic syndrome among US adults: findings from the third national health and nutrition examination survey. JAMA 287, 356–359. <https://doi.org/10.1001/jama.287.3.356>
7. Gayziano, J. M., Hennekens, C. H., O’Donnell, C. J., Breslow, J. L., Buring, J. E. (1997) Fasting triglycerides, high-density lipoprotein, and risk of myocardial infarction. Circulation 96, 2520–2525. <https://doi.org/10.1161/01.CIR.96.8.2520>
8. Guo, Y. Z., Pan, L., Du, C. J., Ren, D. Q., Xie, X. M. (2013) Association between C-reactive protein and risk of cancer: a meta-analysis of prospective cohort studies. Asian Pac. J. Cancer Prev. 14, 243–248. <https://doi.org/10.7314/APJCP.2013.14.1.243>
9. Häggström, C., Rapp, K., Stocks, T., Manjer, J. Bjørge, T., Ulmer, H., Engeland, A., Almqvist, M., Concin, H., Selmer, R., Ljungberg, B., Tretli, S., Nagel, G., Hallmans, G., Jonsson, H., Stattin, P. (2013) Metabolic factors associated with risk of renal cell carcinoma. PLoS One 8(2), e57475. <https://doi.org/10.1371/journal.pone.0057475> <PubMed>
10. Hernandez, A. V., Pasupuleti, V., Benites-Zapata, V. A., Thota, P., Deshpande, A., Perez-Lopez, F. R. (2015) Insulin resistance and endometrial cancer risk: A systematic review and meta-analysis. Eur. J. Cancer 51(18), 2747–2758. <https://doi.org/10.1016/j.ejca.2015.08.031>
11. Horiguchi, A., Ito, K., Sumitomo, M., Kimura, F., Asano, T., Hayakawa, M. (2008) Decreased serum adiponectin levels in patients with metastatic renal cell carcinoma. Jpn. J. Clin. Oncol. 38, 106–111. <https://doi.org/10.1093/jjco/hym158>
12. Hsieh, S. D., Yoshinaga, H. (1999) Do people with similar waist circumference share similar health risks irrespective of height? Tohoku J. Exp. Med. 188, 55–60. <https://doi.org/10.1620/tjem.188.55>
13. Ibrahim, M. M. (2010) Subcutaneous and visceral adipose tissue: structural and functional differences. Obes. Rev. 11, 11–18. <https://doi.org/10.1111/j.1467-789X.2009.00623.x>
14. Inoue, M., Noda, M., Kurahashi, N., Iwasaki, M., Sasazuki, S., Iso, H., Tsugane, S. (2009) Impact of metabolic factors on subsequent cancer risk: results from a large-scale population-based cohort study in Japan. Eur. J. Cancer Prev. 18, 240–247. <https://doi.org/10.1097/CEJ.0b013e3283240460>
15. Jeppesen, J., Hein, H. O., Suadicani, P., Gyntelberg, F. (1997) Relation of high TG-low HDL cholesterol and LDL cholesterol to the incidence of ischemic heart disease. An 8-year follow-up in the Copenhagen Male Study. Arterioscler. Thromb. Vasc. Biol. 17, 1114–1120. <https://doi.org/10.1161/01.ATV.17.6.1114>
16. Jones, J., Libermann, T. A. (2007) Genomics of renal cell cancer: the biology behind and the therapy ahead. Clin. Cancer Res. 13(2 Pt 2), 685s–692s. <https://doi.org/10.1158/1078-0432.CCR-06-1867>
17. Lee, C. M., Huxley, R. R., Wildman, R. P., Woodward, M. (2008) Indices of abdominal obesity are better discriminators of cardiovascular risk factors than BMI: a meta-analysis. J. Clin. Epidemiol. 61, 646–653. <https://doi.org/10.1016/j.jclinepi.2007.08.012>
18. Ljungberg, B., Bensalah, K., Canfield, S., Dabestani, S., Hofmann, F., Hora, M., Kuczyk, M. A., Lam, T., Marconi, L., Merseburger, A. S., Mulders, P., Powles, T., Staehler, M., Volpe, A., Bex, A. (2015) EAU guidelines on renal cell carcinoma: 2014 update. Eur. Urol. 67(5), 913–924. <https://doi.org/10.1016/j.eururo.2015.01.005>
19. Nambiar, S., Truby, H., Abbott, R. A., Davies, P. S. W. (2009) Validating the waist-height ratio and developing centiles for use amongst children and adolescents. Acta Paediatr. 98(1), 148–152. <https://doi.org/10.1111/j.1651-2227.2008.01050.x>
20. Ozbek, E., Otunctemur, A., Sahin, S., Dursun, M., Besiroglu, H., Koklu, I., Polat, E. C., Erkoc, M., Danis, E., Bozkurt, M. (2013) Renal cell carcinoma is more aggressive in Turkish patients with the metabolic syndrome. Asian Pac. J. Cancer Prev. 14(12), 7351–7354. <https://doi.org/10.7314/APJCP.2013.14.12.7351>
21. Ozbek, E., Otunctemur, A., Dursun, M., Koklu, I., Sahin, S., Besiroglu, H., Erkoc, M., Danis, E., Bozkurt, M. (2014) Association between the metabolic syndrome and high tumor grade and stage of primary urothelial cell carcinoma of the bladder. Asian Pac. J. Cancer Prev. 15, 1447–1451. <https://doi.org/10.7314/APJCP.2014.15.3.1447>
22. Patard, J. J., Tazi, H., Bensalah, K., Rodriguez, A., Vincendeau, S., Rioux-Leclercq, N., Guillé, F., Lobel, B. (2004) The changing evolution of renal tumours: a single center experience over a two-decade period. Eur. Urol. 45, 490–493. <https://doi.org/10.1016/j.eururo.2003.12.015>
23. Rodriguez, C., Patel, A. V., Mondul, A. M., Jacobs, E. J., Thun, M. J., Calle, E. E. (2005) Diabetes and risk of prostate cancer in a prospective cohort of US men. Am. J. Epidemiol. 161, 147–152. <https://doi.org/10.1093/aje/kwh334>
24. Shanks, J. H. (1999) Pathology of renal cell carcinoma: recent developments. Clin. Oncol. (R. Coll. Radiol.) 11, 263–268. <https://doi.org/10.1053/clon.1999.9060>
25. Van Hemelrijck, M., Garmo, H., Hammar, N., Jungner, I., Walldius, G., Lambe, M., Holmberg, L. (2012) The interplay between lipid profiles, glucose, BMI and risk of kidney cancer in the Swedish AMORIS study. Int. J. Cancer 130, 2118–2128. <https://doi.org/10.1002/ijc.26212>
26. Wakabayashi, I., Daimon, T. (2015) The “cardiometabolic index” as a new marker determined by adiposity and blood lipids for discrimination of diabetes mellitus. Clin. Chim. Acta 438, 274–278. <https://doi.org/10.1016/j.cca.2014.08.042>
27. Wulaningsih, W., Garmo, H., Holmberg, L., Hammar, N., Jungner, I., Walldius, G., Van Hemelrijck, M. (2012) Serum lipids and the risk of gastrointestinal malignancies in the Swedish AMORIS study. J. Cancer Epidemiol. 2012, 792034. <https://doi.org/10.1155/2012/792034> <PubMed>
28. Zhang, J., Chen, Q., Li, Z. M., Xu, X. D., Song, A. F., Wang, L. S. (2018) Association of body mass index with mortality and postoperative survival in renal cell cancer patients, a meta-analysis. Oncotarget 9(17), 13959–13970.
29. Zhu, Y., Wang, H. K., Zhang, H. L., Yao, X. D., Zhang, S. L., Dai, B., Shen, Y. J., Liu, X. H., Zhou, L. P., Ye, D. W. (2013) Visceral obesity and risk of high grade disease in clinical T1a renal cell carcinoma. J. Urol. 189(2), 447–453. <https://doi.org/10.1016/j.juro.2012.09.030>
front cover

ISSN 1214-6994 (Print) ISSN 2336-2936 (Online)

Archive